Skip to main content
锦波生物 logo

锦波生物 — Investor Relations & Filings

Ticker · 920982 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2025-08-20 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920982

About 锦波生物

https://www.sxjbswyy.com/

Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of functional proteins through synthetic biology. The company is recognized for its industrialization of recombinant humanized collagen, specifically Type III collagen with a stable triple helix structure. Its core business encompasses the production of medical-grade biomaterials, functional skincare products, and medical devices used in aesthetics, wound healing, and gynecological health. By utilizing advanced protein engineering, the company provides biocompatible solutions designed for tissue repair and anti-aging applications. Its technical focus remains on the structural optimization and large-scale production of high-purity recombinant proteins to meet clinical and consumer health demands.

Recent filings

Filing Released Lang Actions
关于召开2025年第四次临时股东会通知公告（提供网络投票）
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a notice announcing the convening of the 2025 fourth extraordinary general meeting of shareholders (临时股东会) of Shanxi Jinbo Biopharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items, registration procedures, and proxy authorization forms. The document does not contain any financial statements or results but serves as an official announcement to shareholders about the meeting and voting process. The document length is 3716 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is primarily a notice of the meeting and voting arrangements rather than solicitation materials or proxy statements, the best fit is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-08-20 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure of the company's Information Disclosure Management System, including principles, procedures, and requirements for periodic and interim reports, temporary reports, and other disclosures. It references regulatory compliance with Chinese securities laws and the Beijing Stock Exchange rules. The content is a governance and procedural document about how the company manages information disclosure, not an actual financial report or announcement of voting results, capital changes, or earnings. It does not contain financial statements or earnings data, nor is it a transcript or presentation. It is a governance-related document detailing internal rules and practices for disclosure. Therefore, the most appropriate classification is Governance Information (CGR). The document length and detail support a high confidence in this classification.
2025-08-20 Chinese
独立董事专门会议制度
Governance Information Classification · 95% confidence The document is a detailed description of the company's internal governance rules specifically related to the Independent Directors' Special Meeting System. It includes procedural rules, voting mechanisms, and the scope of authority for independent directors. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document outlining internal rules and practices. Therefore, it fits the category of Governance Information (CGR). The document length is 2684 characters, which is sufficient for a substantive governance report rather than a brief announcement.
2025-08-20 Chinese
董事会秘书工作细则
Governance Information Classification · 100% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules'. It details the internal governance rules, qualifications, appointment, duties, and responsibilities of the company's board secretary. It references relevant laws and regulations, the company's articles of association, and the role of the board secretary in corporate governance and compliance. There are no financial statements, earnings data, or audit information. The document is a governance-related internal policy document approved by the board. It is not an announcement of a report, nor a report itself. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-20 Chinese
董事会审计委员会工作细则
Governance Information Classification · 100% confidence The document is titled "董事会审计委员会工作细则" which translates to "Board Audit Committee Working Rules." It details the structure, responsibilities, meeting procedures, and authority of the audit committee under the board of directors of Shanxi Jinbo Biopharmaceutical Co., Ltd. It includes references to company law, securities law, and stock exchange listing rules, but it is not a financial report, audit report, or announcement of financial results. It is a governance document outlining internal rules and governance practices related to the audit committee. The document is over 5,000 characters and contains detailed governance content rather than a report or announcement. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-20 Chinese
董事、高级管理人员离职管理制度
Board/Management Information Classification · 95% confidence The document is titled '董事、高级管理人员离职管理制度' which translates to 'Board and Senior Management Departure Management System'. It details the internal rules and procedures regarding the resignation, dismissal, and obligations of directors and senior management personnel. It includes sections on eligibility, resignation procedures, handover processes, obligations after departure, and accountability mechanisms. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related policy or internal regulation issued by the company board. Therefore, it fits best under 'Board/Management Information (MANG)' as it concerns management personnel changes and related governance policies rather than a formal announcement of a change or a financial report.
2025-08-20 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.